FindTrial
Sign In

Clinical testing of the smartphone based device for early cervical cancer diagnosis

Clinical testing of smartphone based upgraded form of existing fluorescence spectroscopic device for early cervical cancer diagnosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040066
Enrollment
100
Registered
2022-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B977- Papillomavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Cervical cancer detection device: This device is a smartphone based fluorescence spectroscopic device which will be used for detecting early cervical cancer detection. Intervention2: Pa

Sponsors

PhotoSpIMeDx Private Limited
Lead Sponsor
Dr Kiran Pandey
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Women patients who visit the OPD and have symptoms or not of cervical cancer.

Exclusion criteria

Exclusion criteria: No criteria

Design outcomes

Primary

MeasureTime frame
The outcome of study is the fluorescence signal captured from the patients that provide the biochemical changes happening inside the tissues during cancer progression. The fluorescence signal captures the changes of certain biomarkers which are present intrinsically such as FAD, Porphyrin, NADH etc. There concentration changes as as the cancer progresses inside the human.Timepoint: The outcome of the study will be assessed after every 4 weeks from the date of trials start.—

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable—

Countries

India

Contacts

Public ContactShikha Ahirwar

GSVM Medical College, Kanpur

dr.kiranpandey@gmail.com9415050322

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026